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Abstract: In many human cell types, the class I phosphoinositide 3-kinases 
play key roles in the control of diverse cellular processes including growth, 
proliferation, survival and polarity. This is achieved through their activation by 
many cell surface receptors, leading to the synthesis of the phosphoinositide 
lipid signal, PIP3, which in turn influences the function of numerous direct 
PIP3-binding proteins. Here we review PI3K pathway biology and analyze the 
evolutionary distribution of its components and their functions. The broad 
phylogenetic distribution of class I PI3Ks in metazoa, amoebozoa and 
choannoflagellates, implies that these enzymes evolved in single celled 
organisms and were later co-opted into metazoan intercellular 
communication. A similar distribution is evident for the AKT and Cytohesin 
groups of downstream PIP3-binding proteins, with other effectors and pathway 
components appearing to evolve later. The genomic and functional phylogeny 
of regulatory systems such as the PI3K pathway provides a framework to 
improve our understanding of the mechanisms by which key cellular 
processes are controlled in humans. 
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Introduction: 
 
All cells use a variety of biochemical mechanisms to control their behaviour in 
response to changes in their environment, whether they are single cells or 
those making up a large complex organism. The PI 3-kinase/PTEN signalling 
network is an important biochemical component in this signal transduction 
process, and which is best recognized as a regulator of cell growth, 
proliferation and survival in many cell types. A consequence of these 
functions is that loss of control of PI3K signalling is a frequent characteristic of 
human disease, particularly many cancers, in which aberrant activation of 
PI3K itself or loss of the opposing phosphatase, PTEN, are frequently 
observed events. In this review, we summarize our current understanding of 
the pathway, analyze the evolutionary distribution of pathway components 
and relate this knowledge with its functions in human cells. 
 
The Phosphoinositide 3-Kinases (PI3Ks) 
 
Phosphoinositide 3-kinases (PI3Ks) are enzymes which phosphorylate 
membrane phosphoinositide lipids at the 3-hydroxyl group of the inositol ring 
(Engelman et al., 2006, Vanhaesebroeck et al., 1997a, Whitman et al., 1988). 
Their lipid products act as cellular signals, directly regulating diverse lipid-
binding effector molecules and thus cellular processes including membrane 
trafficking, cell growth, proliferation, metabolism, migration and polarity (Katso 
et al., 2001, Martin-Belmonte et al., 2008, Vivanco and Sawyers, 2002). 
Based on substrate preference and sequence similarity of the catalytic 
subunit, PI3Ks are classified in three groups, classes I, II and III (Engelman, 
2006, Vanhaesebroeck et al., 2001, Vanhaesebroeck, 1997a, Wymann and 
Pirola, 1998). Class II PI3Ks are monomeric multi-domain proteins, which 
most clearly phosphorylate phosphatidylinositol (PtdIns) to produce PtdIns3P 
and also may generate PI(3,4)P2 during endocytosis (Posor et al., 2013, 
Vanhaesebroeck et al., 2012). Class III PI3Ks are heterodimeric poteins, first 
identified in yeast. Their preferred substrate in vivo is PtdIns and they are 
mainly responsible for the production of most cellular PtdIns3P. Class I PI3Ks 
are the most heavily studied of all PI3Ks; they can catalyze the 
phosphorylation of PtdIns, PtdIns4P or PtdIns(4,5)P2 in vitro but their 
preferred cellular substrate is PtdIns(4,5)P2, leading to the synthesis of 
PtdIns(3,4,5)P3, often known as PIP3. Class I PI3K activity can stimulated 
rapidly (seconds) by extracellular signals through membrane receptors 
including RTKs (Receptor Tyrosine Kinases) and GPCRs (G-Protein coupled 
receptors) and has been heavily implicated in oncogenic transformation (Yuan 
and Cantley, 2008). 
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Class I PI3Ks 
 
Class I PI3Ks are heterodimers, which consist of a catalytic subunit, p110 
(four variants in humans, p110α, p110β, p110δ and p110γ) and one of a 
range of regulatory subunits (p85α, p85β, p55α, p50α, p55γ, p101 or p84) 
(Beck et al., 2014, Engelman, 2006, Stephens and Hawkins, 2011, 
Vanhaesebroeck, 1997a). Human Class I PI3Ks are further divided into two 
subclasses based on their subunit composition and mode of activation. In the 
Class IA enzymes, (p110α, p110β and p110δ, encoded by three different 
genes,  PIK3CA, PIK3CB and PIK3CD respectively), the p110 subunit binds 
with an SH2 domain-containing regulatory subunit (p85α, p85β or p55γ, 
encoded by PIK3R1, PIK3R2 and PIK3R3 respectively, or p55α and p50α, 
splice variants of PIK3R1). These phospho-tyrosine binding SH2 domains 
allow regulation by Receptor Tyrosine Kinases, although p110β can be 
activated by either RTKs or G Protein Coupled Receptors (Maier et al., 1999, 
Tang and Downes, 1997). In contrast, class IB PI3K (p110γ) has a catalytic 
p110 subunit which binds to a p101 or p84 regulatory subunit and is activated 
by GPCRs. All of the p110 isoforms appear to be activated by direct 
interaction with small GTPases; in the case of p110,  and , this appears to 
be RAS isoforms, whereas p110 appears to be co-activated by RAC (Fritsch 
et al., 2013). Comparing genomic data implies evolutionary conservation of 
the PI3Ks, showing that one class I PI3K gene is present in D. melanogaster, 
C. elegans and three in D. discoideum (Engelman, 2006). However, the 
functional expansion provided by the four catalytic subunits appears to be 
restricted to vertebrates and some other chordates (Brown and Auger, 2011, 
Kawashima et al., 2003). 
 
Class I PI3Ks are multi-domain proteins. Although all class I catalytic subunits 
are encoded by separate genes they share a similar domain organization, 
with, in order from the N-terminus, a p85 binding or Adapter binding domain 
(ABD specifically conserved in Class IA p110,  and ), a Ras binding 
domain (RBD), a C2 domain, a helical domain (PIK) and a catalytic kinase 
domain at the C-terminus. The regulatory subunits of class IA all have a 
common core structure consists of p110 binding domain (also termed the 
iSH2) flanked by two Src-homology 2 (SH2) domains which bind to phospho-
tyrosine residues in activated RTKs or adapter proteins and are thereby 
responsible for translocation to and activation of the PI3K holoenzyme at the 
plasma membrane (Burke and Williams, 2013, Vanhaesebroeck, 2012, Yu et 
al., 1998). The longer variants i.e. p85α and p85β, also contain an N-terminal 
SH3 domain and a BCR-homology (BH) domain with potential GTPase 
activating activity, flanked by two proline rich regions (Fruman et al., 1998). 
 
 
Kriplani et al 
	
4 
	
 
Isoform specific PI3K signalling 
 
The existence and differential expression of functionally diverged catalytic and 
regulatory subunits in different tissues or cell types suggests isoform specific 
signalling. p110α, p110β, p85α and p85β seem to be present ubiquitously 
with little evidence for selective heterodimeric pairing, but with some variation 
in levels of expression. p55γ has been reported to be restricted to liver cells, 
however expression of p110γ, p110δ, p101 and p84 is most evident in blood 
cells (Stephens and Hawkins, 2011, Vanhaesebroeck, 2001, Vanhaesebroeck 
et al., 1997b). The generation of isoform specific knock out (KO) mice, kinase 
dead mutant knock-in (KI) mice, work using microinjection of isoform specific 
anti-catalytic antibodies and isoform specific inhibitors has given much more 
insight into isoform specific signalling which has been reviewed well 
(Vanhaesebroeck et al., 2010a). Briefly, full deletion of either p110α or p110β 
leads to embryonic lethality and both enzymes appear to play important and 
distinctive roles in growth and development (Jia et al., 2008, Vanhaesebroeck, 
2010a). Functional loss of p110 or  on the other hand leads to impaired 
immune functions and has motivated the targeting of these enzymes for 
inflammatory disease (Hirsch et al., 2000, Okkenhaug et al., 2002, Sasaki et 
al., 2000). 
 
Phosphoinositides: ubiquitous eukaryotic signals 
 
PtdIns and its phosphorylated derivatives, including the lipid products of 
PI3Ks (class I, II and III) or other classes of PI kinases, are collectively called 
phosphoinositides (PIs) and are found throughout animals, plants, fungi and 
other eukaryotes that have been investigated (Michell, 2008). Structurally PIs 
are amphipathic molecules composed of D-myo inositol 1-phosphate polar 
head group, which faces the cytosolic side of the cell, attached via its 
phosphate group to diacylglycerol (DAG) which sits within the lipid bilayer, 
including two fatty acid chains which in mammals are most commonly found 
to correspond to arachidonic acid and stearic acid. The inositol head group 
can be phosphorylated at the 3rd, 4th or 5th hydroxyl group, whereas the 2nd 
and 6th positions of inositol ring have not been known to become 
phosphorylated in phosphoinositide lipids. In metazoans, PIP3, the lipid 
product of class I PI3Ks is known to act as an indispensable signal regulating 
diverse cellular processes with implications in both health and diseases. 
However, in yeast, although production of PIP3 has been reported in S. 
pombe (Mitra et al., 2004) it appears to be detrimental to growth of S. 
cerevisiae (Rodriguez-Escudero et al., 2005). However other 
phosphoinositides including the class I PI3K substrate PI(4,5)P2, appear to 
play important roles throughout the eukaryotes, including regulating cell 
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division and polarity in budding yeast (Bertin et al., 2010, Strahl and Thorner, 
2007). 
 
Interpreting the language of lipids: PH domain containing PI3K effectors 
 
The class I PI3Ks influence cellular behavior through a diverse group of PIP3-
binding effector proteins (Fig. 1), in humans numbering at least 30 and 
possibly as many as 100. These effector proteins contain a lipid-binding 
domain in their structure with selective affinity for PIP3, and in some cases 
causing bulk translocation of the protein onto the plasma membrane when 
PIP3 levels rise. The most common lipid binding domain among various 
downstream effector proteins is the Pleckstrin Homology (PH) domain. The 
function most commonly attributed to PH domains has been this selective 
binding to phosphoinositide lipids (Haslam et al., 1993, Mayer et al., 1993), 
but importantly, analyses suggest that most do not possess this ability and 
play other roles (Lemmon, 2008, Yu et al., 2004). PH domains are 
evolutionary conserved (Lemmon, 2008) and approximately 120 amino acid 
long with, in the human genome, 323 examples of the domain reported in 276 
different independent gene products (Leslie et al., 2012) but it is strongly 
expected that most have functions unrelated to phosphoinositides. The PH 
domains that have been shown to function in binding PIP3 include the serine 
threonine kinases AKT and PDK1, protein tyrosine kinases of Bruton’s 
tyrosine kinases (BTKs) and Tec family, the Cytohesins (GRP1/ARNO), and 
further more diverse GEFs (Guanine nucleotide Exchange Factors) and GAPs 
(GTPase Activating Proteins) for GTPases of the ras superfamily (Leslie, 
2012, Park et al., 2008, Vanhaesebroeck, 2012). 
 
The AKT and PDK1 kinases 
 
The most heavily studied downstream mediators of PI3K function are the AKT 
kinases, also known as PKB (Protein Kinase B) which belong to the AGC 
family of Serine/Threonine kinases. They are activated in response to 
increased PIP3 levels by two stable phosphorylation events. First, their PH 
domain-mediated translocation to the plasma membrane upon stimulated 
production of PIP3 brings about a conformational change in the kinase. This in 
turn allows phosphorylation at the T308 position (numbering from human 
AKT1) in the activation loop by another PH domain-containing PI3K effector 
and protein kinase PDK1 (Alessi et al., 1997, Stephens et al., 1998) and at 
S473 position in the hydrophobic region of the C-terminal regulatory domain 
by TORC2 (Fayard et al., 2005, Sarbassov et al., 2005) which stabilizes the 
active conformation (Yang et al., 2002). Once activated, AKT can move into 
the cytoplasm or nucleus and phosphorylates a large number of substrates, 
leading to regulation of diverse cellular processes (Manning and Cantley, 
2007, Toker and Marmiroli, 2014). In contrast to AKT, PDK1 is often 
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considered a constitutively active enzyme and it also activates several 
kinases other than AKT. Accordingly, the higher affinity of its PH domain for 
PIP3 combined with its ability to bind to PtdSer ensure that a significant 
fraction of cellular PDK1 is located at the plasma membrane even in cells with 
very low levels of PIP3 (Lucas and Cho, 2011, Mora et al., 2004). 
 
There is strong evidence from genetics in mice, flies and worms and 
extensive characterization of signalling pathways in mammalian cells showing 
the key role of the AKT kinases in mediating many of the cellular effects of 
PI3K activation, particularly those on cell growth, proliferation and metabolism 
(Manning and Cantley, 2007, Toker and Marmiroli, 2014). However, many 
effects of PI3K on other processes, particularly migration and polarity, appear 
to be AKT independent (Charest and Firtel, 2007, Leslie et al., 2008, Liu et al., 
2004). Perhaps the strongest evidence for the importance of AKT in mediating 
effects downstream of PI3K/PTEN is the demonstrated rescue of lethality 
caused by PTEN loss in drosophila that can be achieved with a mutation in 
dAKT which reduces the affinity of its PH domain for PIP3 and which supports 
viability despite highly elevated PIP3 levels (Stocker et al., 2002). However, 
flies appear to have far fewer PIP3-binding PH domains than mammals (Park, 
2008) and the relative significance of AKT downstream of PI3K/PTEN in 
humans is controversial, particularly given the commitment put into 
developing drugs targeting the AKT/TOR signalling axis to treat cancers with 
activated PI3K or lacking PTEN. 
 
The Cytohesin family of ARF-GAP proteins 
 
The established PH domain containing PIP3-binding proteins also include the 
cytohesin family of proteins, consisting of four members: cytohesin-1, 
cytohesin-2 (ARNO, Arf nucleotide binding site opener), cytohesin-3 (GRP1, 
general receptor for phosphoinositides) and cytohesin-4. All the members of 
the cytohesin family contain a N-terminal coiled coil (CC) domain, a central 
Sec7 domain and a C-terminal PH domain. The Sec7 domain possesses a 
highly conserved Arf-GEF function which mediates the activation of Arf 
GTPases (Chardin et al., 1996). All the cytohesin protein PH domains appear 
to mediate recruitment to the plasma membrane and thus can allow regulation 
by PI3K (Klarlund et al., 1997, Nagel et al., 1998, Venkateswarlu et al., 1998). 
 
Other PI3K effectors 
 
Many further class I PI3K effector proteins, such as FGD6, were identified by 
functional and/or bioinformatic screening of PH-domains (Dowler et al., 2000, 
Park, 2008). However some unbiased proteomic approaches to identify other 
phosphoinositide lipid binding domains have been highly successful, leading 
to the discovery of further PH domain containing proteins, such as the ARAP 
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proteins (Jungmichel et al., 2014, Krugmann et al., 2002), and others, with 
apparently novel PIP3 and PI(3,4)P2 binding domains (Dixon et al., 2011, 
Dixon et al., 2012, Lee et al., 2005, Lemmon, 2008, Premkumar et al., 2010). 
 
Phosphoinositide phosphatases 
 
The major cellular lipid product of class I PI3Ks, PIP3 is metabolized by 
various 3-, and 5- phosphatases at these positions of the inositol ring 
respectively. A major antagonist of PI3K signaling is the 3-phosphatase PTEN 
(phosphatase and tensin homologue deleted on chromosome 10) which 
converts PIP3 back to its more abundant precursor PI(4,5)P2 (Cantley and 
Neel, 1999, Downes et al., 2001, Stambolic et al., 1998). The 5-phosphatases 
SHIP1/2 (and probably also SHIP) also metabolize PIP3, converting it to the 
alternate signal PI(3,4)P2 which itself contributes to mediating the outcomes of 
PI3K activation (Leslie, 2012). The contribution of PI(3,4)P2 in mediating the 
outcomes of PI3K activation is currently unclear but some evidence, such as 
the tumour suppressor status of INPP4B, a 4-phosphatase which 
dephosphorylates PI(3,4)P2 (Gewinner et al., 2009), implies important roles. 
 
PTEN: a phosphoinositide 3-phosphatase and tumour suppressor 
 
In 1997, two independent research groups first identified PTEN as a 
candidate tumor suppressor (Li et al., 1997, Steck et al., 1997). It exists 
predominantly as a 403 amino acid protein as well as a very interesting but 
only recently identified 576 amino acid secreted isoform, is a member of PTP 
(Protein Tyrosine Phosphatase) family and in vitro has phosphatase activity 
against both protein and lipid substrates (Hopkins et al., 2013, Worby and 
Dixon, 2014). However, its principle substrate appears to be PIP3 
(McConnachie et al., 2003, Salmena et al., 2008). A key determinant of the 
tumour suppressor activity of PTEN seems to be that under normal cellular 
conditions, the PTEN protein pool has substantial constitutive activity keeping 
PIP3 levels tightly regulated and maintaining homeostasis (Leslie and Foti, 
2011, Myers et al., 1998, Stambolic, 1998). The PTEN gene has long been 
known to be the subject of mutation and deletion in cancer, causing loss of 
tumour suppressor function (Bonneau and Longy, 2000, Salmena, 2008). 
However, PTEN levels and it’s activity are controlled at the transcriptional, 
translational and post-translational levels (Bertrand et al., 2014, Leslie, 2008) 
and significantly, evidence has more recently accumulated showing that the 
physiological mechanisms that control PTEN activity are themselves 
dysregulated in cancer, leading indirectly to loss of PTEN function (Leslie and 
Foti, 2011, Poliseno et al., 2010, Silva et al., 2008). 
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5-phosphatase SHIP proteins 
 
The phosphoinositide 5-phosphatases are a large family in mammals of 10 
Mg2+-dependent phosphatases including OCRL, INPP5E, SKIP, SHIP1 and 
SHIP2. Many of them are catalytically active and capable of metabolizing PIP3 
(Astle et al., 2007, Ooms et al., 2009), however SHIP1 (hematopoietic 
restricted) and SHIP2 (more widely expressed) have most clearly been 
demonstrated to regulate PI3K-dependent signalling in cells. Unlike PTEN 
which appears to provide constant activity, the activity of both SHIP1 and 
SHIP2 is increased by tyrosine phosphorylation and regulated membrane 
recruitment (Batty et al., 2007, Rohrschneider et al., 2000). The large 145kDa 
SHIP proteins contain a N-terminal SH2 domain, which helps bind SHIP to 
tyrosine phosphorylated forms of Shc, SHP-2, Doks, certain ITIMs 
(immunoreceptor tyrosine based inhibitory motifs) and ITAMs 
(immunoreceptor tyrosine based activation motifs). In addition, SHIP proteins 
contain a centrally located catalytic phosphatase domain, followed by a C2 
domain, potentially involved in allosteric regulation by PtdIns(3,4)P2 and two 
NPXY motifs and four PxxP motifs at C-terminus which are involved in 
protein-protein interactions (Dyson et al., 2012, Rohrschneider, 2000). 
 
The evolution of the Class I PI 3-Kinase signalling network 
 
Class I PI 3-Kinases were discovered and characterized in vertebrates acting 
at the inner leaflet of the plasma membrane, allowing the cells of these 
multicellular organisms to interpret intercellular signals such as hormones, 
growth factors and neurotransmitters (Downes and Carter, 1991, Parker and 
Waterfield, 1992). Since then, the roles of these PI3Ks in the regulation of cell 
proliferation, growth and survival in response to intercellular communication 
has been intensely studied and conserved functions in invertebrates such as 
flies and worms have been established (Engelman, 2006). However, genome 
sequence analysis can help identify key components of the signalling network, 
including class I PI3K enzymes themselves, in many single celled organisms. 
The results imply that the network must have existed in a single celled 
common ancestor in which it fulfilled somewhat different functions. Notably, in 
animals, the identification of localised pools of PIP3 in the leading edge of 
cells such as neutrophils undergoing chemotaxis, in axonal growth cones 
during neuronal polarization and in the basolateral membranes of some 
 퉐 퍌 퍎 퓔 퓖 햶 햸 휠 휢    
                    流 琉
and Downward, 1999, Weiner, 2002). Similar polarization of PI3K signalling 
has been observed during directed cell migration in the protozoan 
Dictyostelium discoideum (Charest and Firtel, 2006, Iijima et al., 2002, 
Weiner, 2002). Therefore, it is tempting to speculate that the ancestral role for 
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class I PI3K may perhaps relate to chemotaxis and feeding and the linked 
remodeling of metabolism in response to nutrient availability. Here we present 
and discuss an analysis of recent available genome sequence information. 
 
Eukaryotic conservation of PI kinase and phosphatases 
 
The genomes of most groups of single celled organisms and perhaps all 
multicellular organisms contain both phosphoinositide kinases with similarity 
to the class I PI3Ks and cysteine dependent phosphoinositide phosphatases 
related to PTEN. These extensively conserved enzymes are most similar to 
the related human phosphoinositide 4-kinases and class III PI 3-kinases (the 
latter also known as PIK3C3 or VPS34) and to the Myotubularin and Sac 
groups of PI phosphatases. In terms of apparent evolutionary distance from 
humans, each of the enzyme groups is observed in most eukaryotic genomes, 
including fungi, amoebozoa, plants, the chromalveolata group (including 
alveolates and stramenopiles and rhizaria) and excavates such as giardia. 
 
Enzymes of PIP3 synthesis and metabolism 
 
Class I PI3K catalytic subunits sequentially contain a Ras-binding domain, a 
C2 domain and a C-terminal PI-kinase domain and proteins with this domain 
structure and sequence similarity closest to class I enzymes are found 
throughout many unikonts, including amoebozoa, fonticula, 
choannoflagellates and animals, with the notable exception of the fungi. 
Functional studies provide confidence that these unikont enzymes represent 
true class I PI3Ks (Clark et al., 2014) supported by phylogenetic analyses 
(Brown and Auger, 2011) and are shown in Fig. 2. Class I PI3Ks synthesize 
PIP3 from PI(4,5)P2 and are related to the class II PI3K enzymes which 
synthesize PI3P and in some cases PI(3,4)P2 (Posor, 2013, Vanhaesebroeck, 
2012). However, the Class I and II PI3K catalytic subunits display extensive 
structural similarity, with the class II enzymes also sequentially containing a 
Ras-binding domain, a C2 domain and a C-terminal PI-kinase domain, making 
the two groups difficult to distinguish from amino acid sequence without 
functional data. In more distantly related phylogenetic groups, although such 
class I/II PI3Ks appear to be absent from prokaryotes, from many excavates 
and stramenopiles and from almost all plants, they are present in many other 
diverse eukaryotic groups. These PI3Ks are found in several parasitic 
excavates such as kinetoplastid trypanosomes, trichomonas, naegleria and 
giardia (Cox et al., 2006) and examples are also identifiable in the genomes of 
several alveolates (eg Tetrahymena thermophila, XP_001022838; 
Ichthyophthirius multifiliis, XP_004025156; Paramecium tetraurelia, 
XP_001451414) and a few stramenopiles (eg. Albugo candida, CCI1092; 
Phytophthora infestans, XP_002905219). Without functional data, their firm 
functional classification into class I or class II is difficult, but comparisons with 
Kriplani et al 
	
10 
	
class I enzyme sequences including Dictyostelium discoideum PI3Ks finding 
modestly greater similarity to these divergent eukaryote PI3Ks and the acutely 
regulated synthesis of PIP3 in Dictyostelium (Clark, 2014) imply that class I 
PI3K signalling may be more broadly distributed than previously proposed. It 
is difficult to distinguish whether this broad distribution of Class I/II enzymes in 
more distant eukaryotes indicates loss from specific groups (as seems likely 
for the fungi) or (perhaps less likely given the diversity of groups identified) 
gain by horizontal transfer into specific groups such as the excavate parasites 
(See Fig. 2). 
 
The Class IA regulatory subunits with some similarity to p85, defined here by 
tandem phosphotyrosine-binding SH2 domains and p110-binding inter-SH2 
region, are only evident in animals and close relatives, with the most 
evolutionarily distant protein with this retained domain architecture currently 
identified in the choannoflagellate Salpingoeca rosetta. This is in accordance 
with the distribution of tyrosine kinase based regulatory systems which are 
absent from many other eukaryotic groups. The expansion of the catalytic 
p110 gene family into class 1A and 1B enzymes is evident only in the 
vertebrates and other chordates (eg Ciona intestinalis (Kawashima, 2003)), 
coinciding with the appearance of the class 1B adaptors p101 and p87 which 
lack clear relatives in nematodes or insects. 
 
Phosphatases similar to the human PIP3 3-phosphatase, PTEN, sharing its 
tightly associated Phosphatase-C2 domain architecture are found throughout 
eukaryotes, including fungi, plants, stramenopiles, alveolates and rhizaria and 
euglenozoa. Since some of these organisms lack class I PI3Ks, it would 
appear that some PTEN-like enzymes may function to utilize an alternate 
substrate, or possibly to ensure PIP3 produced by other routes does not 
accumulate, as in some organisms, such as Saccharomyces cerevisiae, PI3K 
activity is strongly deleterious (Rodriguez-Escudero, 2005). On this point it is 
also relevant that in chordate genomes, the closest protein relative of PTEN, 
VSP/TPIP is able to metabolise several phosphoinositides, acting both as a 3- 
and 5-phosphatase (Kurokawa et al., 2012, Walker et al., 2001). Additionally, 
the SHIP group of PIP3 5-phosphatases, including an N-terminal SH2 domain, 
show conservation within animals, choannoflagellates and the related 
Capsaspora, but are not evident in other groups (most of which lack 
phosphotyrosine based signalling mechanisms). Given the existence of many 
phosphoinositide 5-phosphatases with substrates other than PIP3, it is difficult 
from sequence analysis to predict whether other phosphotyrosine-
independent PIP3 5-phosphatases may function in more distantly related 
organisms. 
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Functional conservation of PIP3 signalling – the evolution of PIP3-binding 
proteins 
 
Attempts to analyse the evolutionary diversity of PIP3-binding proteins are not 
simple, as the family of domains most commonly known to function as PIP3-
binders, the pleckstrin homology (PH) domains, also contains many examples 
that lack this capability and in some cases bind to other lipids. In the absence 
of solid functional data, prediction of binding characteristics has proved 
difficult. Therefore, in analyses based on simple sequence similarity and 
retained domain architecture, both the AKT and Cytohesin groups of PIP3-
binding effector proteins show a similar evolutionary distribution to the class I 
PI3K enzymes in unikonts but not fungi, implying highly conserved functions 
for these proteins (Fig. 3). Although these conserved functions are well 
recognized for the AKT kinases (Manning and Cantley, 2007, Paradis and 
Ruvkun, 1998, Stocker, 2002), the functions of the cytohesins are less clearly 
defined. 
 
Proteins structurally related to the human PIP3 binding kinase PDK1 are found 
in many more distant groups of eukaryotes, including plants and fungi which 
lack class I PI3Ks. However the recognized binding of the PDK1 PH domain 
to phosphatidylserine (Lucas and Cho, 2011) and the enzyme’s role 
phosphorylating and activating many PIP3-independent protein kinases 
implies PI3K-independent conserved functions. Similarly, the DH-PH domain 
pair, shared by several PIP3-binding Guanine nucleotide exchange factors for 
the Rac/cdc42 group of GTPases, is also found in many other proteins without 
apparent PIP3-binding capability and is found in many branches of 
eukaryotes. 
 
The apparent evolutionary conservation of PI3K pathway components seems 
likely to reflect conserved functions for these proteins. Studies in invertebrate 
model organisms, particularly flies and worms, have already contributed 
greatly to our understanding of the regulation of cell growth, proliferation and 
movement but further fundamental questions remain unanswered regarding 
the regulation of these processes and the roles of the PI3K network. Further 
motivation for such studies is provided by the availability of drugs to inhibit 
specific PI3K isoforms and some downstream PI3K-activated proteins such as 
AKT and TOR (Martelli et al., 2014, Vanhaesebroeck et al., 2010b). A deeper 
understanding of the underlying biology should help greatly in the successful 
trialing and application of these new therapies. 
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Figure Legends 
 
Fig. 1. Class I PI3K function. The diagram shows a model of PI3K function, 
activated by a receptor at the plasma membrane. Upon receptor engagement 
PtdIns(4,5)P2 (PI(4,5)P2) is phosphorylated by activated PI3K and ATP to 
form PtdIns(3,4,5)P3 (PIP3). and the reverse conversion catalyzed by PTEN, 
reproducing PI(4,5)P2 and releasing free phosphate. Once generated PIP3 is 
able to influence diverse cellular processes through a large number of direct 
PIP3-binding proteins, including AKT, activating Guanine nucleotide exchange 
factors (GEFs) for small GTPases, PDK1, the Cytohesins and many others. 
 
Fig. 2. Eukaryotic phylogenetic tree and the PI3K system. A simplified 
representation of eukaryotic evolutionary relationships is presented. Several 
aspects, particularly the relationships of the deepest branches are uncertain 
(Nozaki et al., 2009, Parfrey et al., 2010, Rogozin et al., 2009). The 
evolutionary distances represented in the tree by branch lengths are indicative 
but do not represent a single quantified analysis. Proteins structurally and 
functionally resembling the human class I PI3Ks are present throughout the 
Unikonts (Episthokonts and Amoebozoa) with the notable exception of fungi. 
PI3K enzymes are also present in the genomes of several more divergent 
eukaryotes (eg some excavate parasites, including trypanosomes and giardia, 
and some alveolates and stramenopiles) but without functional 
characterisation they are difficult to classify into the class I or class II PI3K 
groups. Both the regulatory p85 PI3K subunits and SHIP 5-phosphatases 
appear to be a more recent evolutionary development, appearing only in 
metazoa and chaonnoflagellates.  
 
Fig. 3. Occurrence of PI3K pathway components in eukaryotic groups. The 
patterns of occurrence of individual components of the PI3K signalling system 
is shown, relating to the phylogenetic tree shown in Fig. 2. Lineages or 
species are shown in pink shading, in which each protein represented below 
is evident. It should be noted (*) that proteins with similarity to class I p110 
PI3K are present in some species from the more diverse lineages noted, but it 
is not clear whether these represent class I or class II enzymes. Otherwise a 
pattern of distribution is shred between p110, AKT and the cytohesins, being 
found in unikont groups other than fungi. Also, the Giardia intestinalis genome 
contains a phosphatase with sequence similarity to the PTEN catalytic domain 
but lacking evident amino acid sequence or 3D structural alignment to the 
adjacent C2 domain, which has been used here as the defining feature of the 
PTEN enzyme group. 
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